207 related articles for article (PubMed ID: 32740174)
1. A systematic review on the mechanisms of malignant transformation of oral submucous fibrosis.
Phulari RGS; Dave EJ
Eur J Cancer Prev; 2020 Sep; 29(5):470-473. PubMed ID: 32740174
[TBL] [Abstract][Full Text] [Related]
2. Oral submucous fibrosis: An enigmatic morpho-insight.
Hande AH; Chaudhary MS; Gawande MN; Gadbail AR; Zade PR; Bajaj S; Patil SK; Tekade S
J Cancer Res Ther; 2019; 15(3):463-469. PubMed ID: 31169205
[TBL] [Abstract][Full Text] [Related]
3. Oral submucous fibrosis: An update on pathophysiology of malignant transformation.
Arakeri G; Patil SG; Aljabab AS; Lin KC; Merkx MAW; Gao S; Brennan PA
J Oral Pathol Med; 2017 Jul; 46(6):413-417. PubMed ID: 28391621
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathological characteristics of oral squamous cell carcinoma arising from oral submucous fibrosis: A systematic review.
Divya B; Vasanthi V; Ramadoss R; Kumar AR; Rajkumar K
J Cancer Res Ther; 2023; 19(3):537-542. PubMed ID: 37470571
[TBL] [Abstract][Full Text] [Related]
5. Potential role of fibroblast senescence in malignant transformation of oral submucous fibrosis.
Bijai LK; Muthukrishnan A
Oral Oncol; 2022 Apr; 127():105810. PubMed ID: 35303624
[TBL] [Abstract][Full Text] [Related]
6. Oral squamous cell carcinoma in the background of oral submucous fibrosis is a distinct clinicopathological entity with better prognosis.
Gadbail AR; Chaudhary M; Gawande M; Hande A; Sarode S; Tekade SA; Korde S; Zade P; Bhowate R; Borle R; Patil S
J Oral Pathol Med; 2017 Jul; 46(6):448-453. PubMed ID: 28129456
[TBL] [Abstract][Full Text] [Related]
7. Oral squamous cell carcinoma arising in background of oral submucous fibrosis: a clinicopathologically distinct disease.
Chaturvedi P; Vaishampayan SS; Nair S; Nair D; Agarwal JP; Kane SV; Pawar P; Datta S
Head Neck; 2013 Oct; 35(10):1404-9. PubMed ID: 22972608
[TBL] [Abstract][Full Text] [Related]
8. Molecular profiling of oral squamous cell carcinoma associated with oral submucous fibrosis.
Choudhari S; Masne S; Bhandare P; Dhumal S
J Cancer Res Ther; 2022; 18(1):55-65. PubMed ID: 35381762
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of PTEN immunoexpression in oral submucous fibrosis: role in pathogenesis and malignant transformation.
Angadi PV; Krishnapillai R
Head Neck Pathol; 2012 Sep; 6(3):314-21. PubMed ID: 22392409
[TBL] [Abstract][Full Text] [Related]
10. Malignant transformation of oral submucous fibrosis: overview of histopathological aspects.
Ray JG; Ranganathan K; Chattopadhyay A
Oral Surg Oral Med Oral Pathol Oral Radiol; 2016 Aug; 122(2):200-9. PubMed ID: 27422418
[TBL] [Abstract][Full Text] [Related]
11. Expression of hTERT in Oral Submucous Fibrosis and Oral Squamous Cell Carcinoma - an Immunohistochemical Analysis.
Raju K L; Haragannavar VC; Patil S; Rao RS; Nagaraj T; Augustine D; Venkatesiah SS; Nambiar S
Pathol Oncol Res; 2020 Jul; 26(3):1573-1582. PubMed ID: 31489575
[TBL] [Abstract][Full Text] [Related]
12. Socio-Economic Implications Of A Younger Aged Female Predilection In Malignant Transformation Of Oral Sub Mucous Fibrosis.
Fatima N; Mohiuddin S; Hosein S; Mervyn M
J Ayub Med Coll Abbottabad; 2019; 31(1):16-20. PubMed ID: 30868776
[TBL] [Abstract][Full Text] [Related]
13. Better grade of tumor differentiation of oral squamous cell carcinoma arising in background of oral submucous fibrosis.
Sarode SC; Sarode GS
Med Hypotheses; 2013 Oct; 81(4):540-3. PubMed ID: 23891040
[TBL] [Abstract][Full Text] [Related]
14. Research Achievements of Oral Submucous Fibrosis: Progress and Prospect.
Xu H; Lyu FY; Song JY; Xu YM; Jiang EH; Shang ZJ; Chen LL; Xu Z
Biomed Res Int; 2021; 2021():6631856. PubMed ID: 33791368
[TBL] [Abstract][Full Text] [Related]
15. HIF - 1α as a marker of risk assessment for malignant transformation in oral submucous fibrosis: An immunohistochemical study.
Sharma K; Shetty DC; Rathore AS; Juneja SA; Katyal S; Krishnatre A
Indian J Pathol Microbiol; 2022; 65(4):761-765. PubMed ID: 36308177
[TBL] [Abstract][Full Text] [Related]
16. Oral squamous cell carcinoma associated with oral submucous fibrosis have better oncologic outcome than those without.
Chaturvedi P; Malik A; Nair D; Nair S; Mishra A; Garg A; Vaishampayan S
Oral Surg Oral Med Oral Pathol Oral Radiol; 2017 Sep; 124(3):225-230. PubMed ID: 28606826
[TBL] [Abstract][Full Text] [Related]
17. Oral submucous fibrosis: review on mechanisms of malignant transformation.
Ekanayaka RP; Tilakaratne WM
Oral Surg Oral Med Oral Pathol Oral Radiol; 2016 Aug; 122(2):192-9. PubMed ID: 27289264
[TBL] [Abstract][Full Text] [Related]
18. An update on studies on etiological factors, disease progression, and malignant transformation in oral submucous fibrosis.
Bari S; Metgud R; Vyas Z; Tak A
J Cancer Res Ther; 2017; 13(3):399-405. PubMed ID: 28862199
[TBL] [Abstract][Full Text] [Related]
19. Molecular Mechanisms of Malignant Transformation of Oral Submucous Fibrosis by Different Betel Quid Constituents-Does Fibroblast Senescence Play a Role?
Zhang P; Chua NQE; Dang S; Davis A; Chong KW; Prime SS; Cirillo N
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163557
[TBL] [Abstract][Full Text] [Related]
20. Molecular Pathology of Malignant Transformation of Oral Submucous Fibrosis.
Chattopadhyay A; Ray JG
J Environ Pathol Toxicol Oncol; 2016; 35(3):193-205. PubMed ID: 27910776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
